A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events
Crossref DOI link: https://doi.org/10.1038/tpj.2017.33
Published Online: 2017-07-11
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moretti, M E
Lato, D F
Berger, H
Koren, G
Ito, S
Ungar, W J
Text and Data Mining valid from 2017-07-11
Article History
Received: 6 December 2016
Revised: 8 May 2017
Accepted: 10 May 2017
First Online: 11 July 2017
Competing interests
: The authors declare no conflict of interest.